gemcitabine hydrochloride

Poland

Drugs containing this active substance

  • GEMCITABINE ACCORD

    The medicinal product is used in the treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.

    Form: solution for infusion, powder for preparation of

    Active substance Dosage
    gemcitabine hydrochloride 228 mg

    ATC: L01BC05

    Manufacturer: Accord Healthcare B.V.

  • GEMCITABINE ACCORD

    The medicine is used to treat non-small cell lung cancer (alone or with cisplatin), pancreatic cancer, breast cancer (in combination with paclitaxel), ovarian cancer (in combination with carboplatin), and bladder cancer (in combination with cisplatin).

    Form: solution for infusion, powder for preparation of

    Active substance Dosage
    gemcitabine hydrochloride 1140 mg

    ATC: L01BC05

    Manufacturer: Accord Healthcare B.V.

  • GEMCITABINE ACCORD

    The medicinal product is used in the treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    gemcitabine hydrochloride 113.85 mg/ml

    ATC: L01BC05

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • GEMCITABINE SUN

    The medicinal product is used in the treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.

    Form: solution for infusion

    Active substance Dosage
    gemcitabine hydrochloride 11,384 mg/ml

    ATC: L01BC05

    Manufacturer: Sun Pharmaceutical Industries Europe B.V.

  • GEMSOL

    The drug is used in the treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    gemcitabine hydrochloride No input provided

    ATC: L01BC05

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH